Companies / Spain
Branded Drug Firms Attack Generics Rules
October 2006 | Legal NewsInnovator drug companies operating in Spain have launched an attack on provisions regarding generic substitution in the new Medicines Law. Article 85 encourages pharmacists to substitute branded drugs with a generic formulations of the same API, wherever available. Branded drug firms have argued that this discriminates against their products, partly in view of weaknesses in Spain's patent laws - leading to a likely decline in R&D
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
